Who are intra-rectal botulinum toxin injections's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Botulinum toxin A 150u, botulinum type a, Botulinum Toxin A (Botox ), Botulinum neurotoxin (BTX), Botulinum Toxin Type A Injection [HG102], BOTOX®, Allergan.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/intra-rectal-botulinum-toxin-injections.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

intra-rectal botulinum toxin injections — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

intra-rectal botulinum toxin injections (intra-rectal botulinum toxin injections) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Neuromuscular blocker. Area: Gastroenterology.

phase 3 Neuromuscular blocker SNARE proteins Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

intra-rectal botulinum toxin injections (intra-rectal botulinum toxin injections) — University Hospital, Rouen. Botulinum toxin injections work by blocking the release of acetylcholine at the neuromuscular junction, leading to muscle relaxation.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
intra-rectal botulinum toxin injections TARGET	intra-rectal botulinum toxin injections	University Hospital, Rouen	phase 3	Neuromuscular blocker	SNARE proteins
Botulinum toxin A 150u	Botulinum toxin A 150u	EvergreenHealth	marketed	Neurotoxin; Acetylcholine release inhibitor	SNARE proteins (specifically SNAP-25)
botulinum type a	botulinum type a	Henry Ford Health System	marketed	Neurotoxin; botulinum toxin	SNARE proteins (synaptobrevin, SNAP-25, syntaxin); acetylcholine release machinery
Botulinum Toxin A (Botox )	Botulinum Toxin A (Botox )	Assistance Publique - Hôpitaux de Paris	marketed	Neurotoxin; acetylcholine release inhibitor	SNARE proteins (specifically SNAP-25); acetylcholine release machinery
Botulinum neurotoxin (BTX)	Botulinum neurotoxin (BTX)	The University of Texas Health Science Center, Houston	marketed	Neurotoxin; acetylcholine release inhibitor	SNARE proteins (SNAP-25, VAMP, syntaxin)
Botulinum Toxin Type A Injection [HG102]	Botulinum Toxin Type A Injection [HG102]	Hugel	phase 3	Neurotoxin; botulinum toxin preparation	SNARE proteins (synaptobrevin/VAMP); acetylcholine release machinery
BOTOX®, Allergan	BOTOX®, Allergan	Assistance Publique - Hôpitaux de Paris	phase 3	Botulinum toxin type A	SNARE proteins (specifically SNAP-25)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Neuromuscular blocker class)

Guy's and St Thomas' NHS Foundation Trust · 1 drug in this class
University Hospital, Rouen · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). intra-rectal botulinum toxin injections — Competitive Intelligence Brief. https://druglandscape.com/ci/intra-rectal-botulinum-toxin-injections. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab